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Abstract
Objective: The effects of the beta-3-receptor agonist CGP-12177 on thyroxine (T4) deiodination in
sympathectomized (SX) interscapular brown adipose tissue (BAT) were assessed in 300 g body weight
(BW) Wistar rats.
Design: Seven days after SX, groups of rats were implanted s.c. with pellets containing 5 mg CGP-
12177 or 5 mg norepinephrine (NE) and were immediately placed at 4 8C for 24 h. Other SX groups
were injected with CGP-12177 or NE 1 mg/kg BW i.p. and placed in the cold for 4 h. The latter group
was injected, in addition, with prazosin 0.4 mg/100 g BW i.p. or propranolol 0.5 mg/100 g BW i.p.
15 min before and 2 h after the administration of CGP-12177 or NE.
Methods: Two hours after the last injection of prazosin or propranolol, animals were killed and BAT
was removed, homogenized and centrifuged at 500 g for 10 min at 4 8C. The infranatants were
incubated during 60 min in the presence of dithiothreitol and 1 mCi [125I]T4. Aliquots were
chromatographed on paper for the measurement of [125I]T4 and its deiodinated subproducts.
Results: CGP-12177 restored normal T4 deiodination in SX BAT from both groups, but NE was slightly
more effective. Propranolol, although not prazosin, blocked the CGP-12177 effects. Contrariwise, the
NE-induced rise in deiodination was blocked by prazosin and to a lesser extent by propranolol.
Conclusions: The results indicate that CGP-12177 stimulated the in vivo activation of 50-deiodinase type
II activity predominantly via beta-3-receptor, without participation of alpha-1-receptors.
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Introduction
The ability of brown adipose tissue (BAT) to increase
thermogenesis in response to cold is largely dependent
on the presence of norepinephrine (NE) and the
thyroid hormones (1±6). BAT NE is supplied almost
totally by the sympathetic nerves, whereas BAT
triiodothyronine (T3) is regulated through the activa-
tion of 50-deiodinase type II (50-DII), which converts
thyroxine (T4) to T3 (7). The effects of NE on BAT
uncoupling protein (UCP1) synthesis are mediated
predominantly via beta-3-receptors (8), whereas
alpha-1-receptors (7) and the synergism between
alpha-1- and beta-receptors (9) have been reported to
mediate the synthesis of 50-DII.
The selective beta-3-adrenoreceptor agonist CGP-
12177 activates BAT thermogenesis, as measured by
GDP binding to UCP sites, UCP concentration or
mitochondrial oxygen consumption (10, 11). The
effects of this agonist on BAT 50-DII activity in vivo
are less known. In view of the signi®cance of T4
deiodination in BAT thermogenic activity, the present
work set out to investigate the effects of the in vivo
administration of CGP-12177 on sympathectomized
(SX) BAT 50-DII activity in response to cold. The
effects of NE and a variety of synthetic agonists or
antagonists of adrenergic receptors have long been
thoroughly investigated. The present work studied the
effects of NE on 50-DII activity only, for comparison




Male Wistar rats (Department of Zoology, University of
Graz) of approximately 300 g body weight (BW) were
used. Purina rat chow and water were freely available in
a room with lights on between 0600 and 2000 h.
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Reagents
Double-labeled [30,50-125I]T4 with a speci®c activity of
1280 mCi/mg was purchased from Amersham Interna-
tional plc, Amersham, Bucks, UK, and was used within
a week of arrival. It was 95% pure and the rest was 125I
and traces of [125I]T3. The proportions of these
contaminants were determined in duplicate by chro-
matographic runs in each experiment and were
substracted from the results. 1,4-Dithio-L-threitol
(DTT), NE bitartrate, prazosin and DL-propranolol were
purchased from Sigma Chemical Co., St Louis, MO, USA.
The beta-3-receptor agonist CGP-12177 was kindly
provided by Novartis, Basel, Switzerland.
Experiment 1
Groups of rats were subjected to BAT SX or sham
operation in the manner described in a previous report
(12). After closing the surgical incision, animals were
returned to individual cages and maintained at ,24 8C
with food and water freely available for 7 days. On day
8, sham and SX rats were implanted, s.c., under light
ether anesthesia, with pellets containing either 5 mg
CGP-12177 or 5 mg NE. Another group of SX rats were
implanted with pellets devoid of CGP-12177 or NE, thus
serving as SX controls. The pellets were made up of a
polysaccharide matrix (Eudragit, RoÈhm GmbH, Darm-
stadt, Germany) and the respective adrenergic com-
pound, and were prepared as described elsewhere (13).
Immediately thereafter, rats were placed in individual
cages in a cold-room at 4 8C, with free access to food and
tap water. After 24 h, animals were killed by cervical
dislocation, blood and BAT were obtained and BAT was
immediately processed as described below.
Experiment 2
Groups of SX rats were injected with a single dose of
either CGP-12177 or NE 1 mg/kg BW, i.p. Sham-
operated rats received the vehicle alone. Animals were
immediately placed in individual cages in a cold-room at
4 8C. Fifteen minutes before and 2 h after the injection of
CGP-12177 or NE, rats received prazosin 0.4 mg or
propranolol 0.5 mg/100 g BW, i.p. Rats were killed 2 h
after the last injection of prazosin or propranolol. BAT
was removed and processed. Five rats per group were
studied.
Deiodination studies
BAT homogenates were prepared as described before
(14). Tissue samples were homogenized in ice-cold
buffer containing sucrose (320 mmol/l) and Hepes
(10 mmol/l) in a proportion of 1 g BAT to 4 ml buffer,
pH 7.4. The mixture was centrifuged at 500 g for
10 min at 4 8C. The infranatant (6.8±9.7 mg protein/
ml) contained the deiodinating activity and was used
for the study of T4 deiodination. To 200 ml aliquots of
infranatants were added 10 mmol/l DTT (®nal con-
centration) and 1 mCi [125I]T4 carrying 1 pmol T4.
The ®nal substrate concentration was 5.1 nmol/l. A
previous study (14) showed that larger T4 concentra-
tions (1 mmol/l) were needed to inhibit T4 deiodina-
tion under these experimental conditions. Tissue-free
tubes containing reagents in concentrations similar to
those added to the homogenates, plus labeled T4, were
also prepared. All aliquots and blanks were incubated
in a water-bath under continuous shaking at 37 8C for
60 min. The deiodination reaction was stopped by the
addition of an equal volume of methanol:ammonia
(99:1, v/v). Aliquots (20 ml) of each homogenate and
blanks were applied to Whatman 1 paper and
chromatographed in a tertiary amyl alcohol:hexane:
ammonia (10:1:12, v/v) system together with the
appropriate non-radioactive carriers for approximately
18 h. Chromatograms were cut into 0.5 cm segments
and 125I in them counted. The resulting histograms
allowed a clear identi®cation of the radioactive
compounds, which were correlated with the stained
areas in duplicate strips. Radioactivity in the chroma-
tograms were corrected for the proportion of each
radioactive compound other than [125I]T4 present in
the chromatographic runs of the standard solutions as
received from the commercial source and of blanks
incubated concomitantly with the homogenates. This
chromatographic technique allowed a reliable assess-
ment of the percentage distribution of the radioactive
compounds generated during the incubation of labeled
T4 (15, 16). The absolute amount of [125I]T4 deiodinated
during the incubation period was derived from knowing
the percentage of [125I]T4 present in the homogenates
and the amount of added T4. The values were expressed
in pg/mg of protein/h.
NE measurement
BAT NE was measured by techniques described elsewhere
(17). Brie¯y, BAT was homogenized at 4 8C in perchloric
acid, EDTA and ascorbic acid and centrifuged for 10 min
at 24 000 g. Supernatants were treated with ammonium
chloride, EDTA and a diphenylborate±ethanolamine
complex, and also with octanol±heptane and a tetra-
octylamino±bromide complex. After 5 min stirring and
5 min centrifugation the supernatant was resuspended in
octanol, extracted with acetic acid and injected into an
HPLC apparatus for the analysis of catecholamines using
Beckman System Gold software (Fullerton, CA, USA) and
a BAS-LG-4B electrochemical detector (Biolab, Vienna,
Austria). The limit of detection was 50 pg NE/ml. Results
are expressed as pg/mg wet tissue.
Other methods
Statistical analyses were performed by ANOVA and
Duncan's test.
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Results
Results of BAT weight, protein and NE concentrations
after 24 h of cold exposure are shown in Table 1. BAT
denervation induced a signi®cant decrease in total
proteins (P < 0:01 versus sham group), and this effect
was unchanged by the injection of CGP-12177 or NE.
Seven days after SX, BAT NE declined to the limits of
detection (P<0.01). The values increased markedly after
the implantation of NE pellets but reached only one-half
the concentration of NE seen in normal BAT. BAT
concentration of CGP-12177 could not be determined.
The distribution of deiodinated T4 among its metabolic
subproducts in rats treated with receptor blockers is
seen in Table 2. The results show that more than 97% of
deiodinated T4 was apportioned almost equally between
T3 and iodide, the rest being traces of T2. Comparable
percentages of T3 and iodide production were observed
in rats implanted with pellets (data not shown). Figure 1
shows the absolute T4 deiodinated in rats subjected to
sham or SX operations. Denervation sharply reduced
deiodination (P < 0:01). Normal deiodination was
restored after the implantation of CGP-12177 or NE
pellets. Figure 2 depicts the results from the second
experiment, performed 4 h after the injection of the
adrenergic agonists. Both CGP-12177 and NE restored
normal T4 deiodination in SX rats. Although the study
was terminated at 4 h, it is possible that the stimulatory
action of CGP-12177 may have lasted longer, similar to
the effects of NE seen in earlier studies (18). The effects
of CGP-12177 were abolished by propranolol (P < 0:01)
whereas prazosin failed to induce signi®cant changes.
Because BAT from SX rats was devoid of NE, the results
indicate that propranolol had blocked predominantly or
solely the action of CGP-12177. Conversely, prazosin
was effective in blocking the stimulatory activity of NE
(P < 0:01), as shown in earlier studies of Silva & Larsen.
(7, 18). However, propranolol also impaired the
response to NE (P < 0:05), an effect not seen in those
reports.
Discussion
Activation of BAT thermogenesis involves the binding of
NE to BAT beta-3-adrenergic receptors, followed by the
stimulation of adenylate cyclase (5). Different subtypes
of beta-receptors have tissue selectivity, e.g. beta-1 in
heart, beta-2 in lung and beta-3 in adipose tissue.
However, all three beta-receptors coexist in BAT (19,
20). It is also clear that BAT expresses the genes of the
three beta-receptors and that each receptor mediates a
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Table 1 BAT weight, protein and NE contents after a 24 h cold exposure. Means 6 S.D. BAT NE
was measured in separate groups of similarly treated rats. Numbers in parentheses indicate
number of rats. Pellets containing 5 mg CGP-12177 or NE were implanted s.c. immediately before
animals were placed in a cold-room.
Body weight BAT weight BAT protein BAT NE
Groups (g) (mg) (mg/ml) (pg/mg tissue)
Sham (8) 310 6 28 288 6 33a 10:8 6 1:2a 676 6 85d
SX (8) 328 6 22 221 6 43c 7:6 6 0:8b 90 6 27e
CGP-12177 (7) 315 6 28 238 6 32 8:6 6 1:1c Ð
NE (7) 296 6 25 266 6 32 8:6 6 1:1c 299 6 31e
P values in each column: a versus b< 0:01; a versus c < 0:05; d versus e < 0:01 (ANOVA).
Table 2 T4 deiodination and its subproducts as % of added [125I]T4 in rats studied 4 h after the injection of the
adrenergic agonists. Means 6 S.D. Sham and SX rats were injected with CGP-12177 or NE 1 mg/kg BW, i.p. and
placed in a cold-room at 4 8C. Prazosin and propranolol were injected 15 min before and 2 h after the
administration of the respective adrenergic agonist. Animals were killed 2 h after the last injection of the receptor
blocker. Five rats per group were studied.
[125I]T4 [125I]T3 125I
Groups deiodinated produced produced Others*
Sham 65:2 6 7:6a 32:8 6 3:8a 30:8 6 2:6a 2:3 6 1:9
SX 23:0 6 3:9b 10:6 6 1:8b 11:4 6 2:8b 1:4 6 1:1
SXCGP-12177 56:3 6 5:1c 25:9 6 1:8c 28:9 6 4:3c 2:1 6 1:8
Prazosin 47:5 6 5:1 22:9 6 2:4 23:5 6 2:8 0:9 6 0:7
Propranolol 25:6 6 4:4d 13:2 6 2:3d 10:8 6 1:6d 2:1 6 1:4
SXNE 64:1 6 7:5e 30:8 6 3:2e 32:3 6 3:5e 1:8 6 1:2
Prazosin 28:8 6 4:3f 13:7 6 2:5f 12:9 6 2:1f 1:7 6 1:2
Propranolol 43:1 6 5:9g 20:7 6 2:5g 21:1 6 2:4g 1:5 6 1:3
*Traces of [125I]T3, 30-T2 and other unidenti®ed substances.
P values: a versus b, c versus d and e versus f, < 0:01; e versus g, < 0:02 (ANOVA).
particular stimulatory action of NE (21, 22). The
stimulation of beta-1- and beta-2-adrenoreceptors
activates adenylate cyclase but does not lead to a
thermogenic response in rat BAT, as measured by
oxygen consumption (8). On the other hand, stimula-
tion of the beta-3-receptor activates thermogenesis,
which led to the suggestion that this receptor was
predominantly or solely the adrenergic receptor coupled
to BAT thermogenesis (8).
Early studies performed in vivo by Silva & Larsen (7,
18) had shown that pretreatment of rats with the
speci®c alpha-1-receptor antagonist prazosin inhibited
NE- or cold-stimulated increases in BAT deiodinase.
These ®ndings led to the conclusion that BAT 50-
deiodinase activity was predominantly mediated via
alpha-1-adrenoreceptors, with a minor participation of
beta-receptors. Further studies by Raasmaja & Larsen
(9) performed in cultured brown adipocytes showed a
complex interrelationship between alpha-1- and beta-
receptors, suggesting a synergistic action between these
two types of receptors. The present ®ndings indicate that
the in vivo administration of CGP-12177 stimulated 50-
deiodination with a time-course comparable to that of
NE. The pellets used in this study released the
adrenergic compounds steadily during a period of
approximately 72 h, with a peak between 24 and 48 h
(23). When CGP-12177 was administered by a single
i.p. injection, it restored deiodination to within normal
values, although slightly lower than the effect of NE.
The 4 h effects of CGP-12177 were abolished by
propranolol but not by prazosin, thus con®rming that
beta-receptors were mostly or solely involved in the in
vivo activation of 50-DII. These results correlate with
those obtained in isolated brown adipocytes in vitro by
Pavelka et al. (24) and Hernandez & ObregoÂn (25). In
rats injected with NE, however, prazosin ± and to a
lesser extent propranolol ± blocked the NE effect,
thereby suggesting that the natural agonist activated
50-DII in vivo via alpha-1-receptors and to a lesser extent
through beta-receptors. A selective, high af®nity beta-3-
receptor blocker which would facilitate the analysis of
the results has not yet been identi®ed. We used
propranolol, whose af®nity for beta-3-receptors is far
below (26) its af®nity for beta-1 and beta-2-receptors
(11, 21). Based on the sharp inhibition of CGP-12177
by propranolol and the fact that this adrenergic agonist
interacts with receptors other than those with which NE
interacts (27), one cannot rule out that beta-receptor
subtypes other than beta-3 may have participated in the
BAT response to CGP-12177. NE was slightly more
ef®cient than the synthetic agonist in promoting 50-DII
activity. Other parameters of BAT thermogenesis, such
as oxygen consumption (11) and GDP binding to BAT
mitochondrial proteins (A Zaninovich) also showed that
NE was moderately more effective. This could be the
result of a complex mechanism for the in vivo activation
of 50-DII, which would involve NE and more than one
type of adrenergic receptor. Zhao et al. (28) showed that
both beta-3- and alpha-1-receptors mediated the
activation of BAT oxygen consumption. The alpha-1-
receptor appeared to potentiate the ability of cAMP to
stimulate thermogenesis synergistically with the beta-3-
receptor. A synergism between beta- and alpha-1-
receptors in the stimulation of 50-DII activity was
observed in isolated adipocytes (9) although other
in vitro studies (24, 25) failed to detect a role for
alpha-1-receptors, perhaps due to different cell culture
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Figure 1 Effects of beta-3-adrenergic agonist CGP-12177 and NE
on T4 deiodination in SX BAT. Results are means 6 S.D. Numbers
below bars indicate the number of experiments. Animals were
implanted s.c. with pellets containing CGP-12177 5 mg or NE 5 mg
and exposed to 4 8C for 24 h. Control SX rats were implanted with
pellets devoid of CGP-12177 or NE. Probability values: a versus b,
P < 0:01 (ANOVA and Duncan's test).
Figure 2 T4 deiodination in SX BAT 4 h after the injection of
CGP-12177 or NE 1 mg/kg BW i.p. and a 4 h exposure to 4 8C.
Prazosin (0.4 mg/100 g BW) or propranolol (0.5 mg/100 g BW) was
injected i.p. 15 min before and 2 h after the administration of the
adrenergic agents. Results are means 6 S.D. Five animals per group
were studied. Probability values: a versus b, c versus d and e
versus f, P < 0:01; e versus g, P < 0:02 (ANOVA and Duncan's
test).
conditions. The present data indicate that the in vivo
administration of CGP-12177 can activate BAT 50-DII
via beta-receptors without a signi®cant participation of
alpha-1-receptors. It should be kept in mind, however,
that this pathway may differ from that used by the
natural agonist under physiological conditions.
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